XClose

UCL News

Home
Menu

Drug groups are shifting focus towards more personalised treatments

13 August 2013

Discussing the future of the pharmaceutical industry, Professor Sir John Tooke (UCL Vice Provost, Health) says: "We need far more circulation between academia and industry, (and) we need to recognise that excellent science also occurs in industry." Read: FT (£)